IP Library Granted Patent US 7,125,715
Granted Patent B2
US 7,125,715 · App. 10/240,535 · Granted Oct 24, 2006

Nucleic acid encoding a polypeptide promoting type II collagen formation and aggrecan production

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,125,715
App. No.
10/240,535
Granted
Oct 24, 2006
Kind
B2
Abstract

A novel polypeptide, a polynucleotide encoding this polypeptide, an expression vector comprising this polynucleotide, a cell transfected with the expression vector, and a pharmaceutical composition for promoting type II collagen production, a pharmaceutical composition for promoting aggrecan production, and a pharmaceutical composition for treating and/or preventing osteoarthritis comprising the above polypeptide as an active ingredient are disclosed. The polypeptide exhibits an activity of promoting type II collagen production and/or an activity of promoting aggrecan production.

Claims (7)

1. An isolated polynucleotide encoding a polypeptide selected from:

(a) a polypeptide consisting of an amino acid sequence consisting of amino acids 23 to 388 of SEQ ID NO:2;

(b) a polypeptide consisting of an amino acid sequence consisting of amino acids 1 to 388 of SEQ ID NO: 2;

(c) a polypeptide comprising an amino acid sequence consisting of amino acids 23 to 388 of SEQ ID NO: 2, and exhibiting an activity of promoting type II collagen production and/or an activity of promoting aggrecan production; or

(d) a polypeptide according to any one of (a), (b), or (c), exhibiting both an activity of promoting type II collagen production and an activity of promoting aggrecan production.

2. An expression vector comprising the polynucleotide according to claim 1 .

3. An isolated cell transfected with the expression vector according to claim 2 .

Assignments (1)
CHANGE OF NAME Recorded Nov 16, 2005
From: YAMANOUCHI PHARMACEUTICAL CO., LTD.
To: ASTELLAS PHARMA INC.
Reel/Frame 016784/0361 →